BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22417299)

  • 1. Recent updates on the role of microRNAs in prostate cancer.
    Hassan O; Ahmad A; Sethi S; Sarkar FH
    J Hematol Oncol; 2012 Mar; 5():9. PubMed ID: 22417299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of microRNA dysregulation in the development of prostate cancer.
    Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
    Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-mRNA correlation-network modules in human prostate cancer and the differences between primary and metastatic tumor subtypes.
    Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
    PLoS One; 2012; 7(6):e40130. PubMed ID: 22768240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
    Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
    Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microdissecting the role of microRNAs in the pathogenesis of prostate cancer.
    Ayub SG; Kaul D; Ayub T
    Cancer Genet; 2015 Jun; 208(6):289-302. PubMed ID: 26004033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between aberrant expression of miRNAs and prostate cancer].
    Zhang JY; Yang J; Song NH
    Zhonghua Nan Ke Xue; 2013 Jul; 19(7):657-61. PubMed ID: 23926687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNAs associated with prostate cancer risk and progression.
    Luu HN; Lin HY; Sørensen KD; Ogunwobi OO; Kumar N; Chornokur G; Phelan C; Jones D; Kidd L; Batra J; Yamoah K; Berglund A; Rounbehler RJ; Yang M; Lee SH; Kang N; Kim SJ; Park JY; Di Pietro G
    BMC Urol; 2017 Mar; 17(1):18. PubMed ID: 28320379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
    Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
    Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and prostate cancer.
    Pang Y; Young CY; Yuan H
    Acta Biochim Biophys Sin (Shanghai); 2010 Jun; 42(6):363-9. PubMed ID: 20539944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours.
    Sun R; Fu X; Li Y; Xie Y; Mao Y
    BMC Genomics; 2009 Feb; 10():93. PubMed ID: 19245699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MicroRNAs and prostate cancer].
    Yang CH; Zhang CN
    Zhonghua Nan Ke Xue; 2010 Sep; 16(9):844-9. PubMed ID: 21171273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
    Kumar B; Lupold SE
    Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritizing candidate disease miRNAs by topological features in the miRNA target-dysregulated network: case study of prostate cancer.
    Xu J; Li CX; Lv JY; Li YS; Xiao Y; Shao TT; Huo X; Li X; Zou Y; Han QL; Li X; Wang LH; Ren H
    Mol Cancer Ther; 2011 Oct; 10(10):1857-66. PubMed ID: 21768329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA in prostate cancer: Practical aspects.
    Patil PA; Magi-Galluzzi C
    Histol Histopathol; 2015 Dec; 30(12):1379-96. PubMed ID: 26186079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Different Types of microRNA in the Pathogenesis of Breast and Prostate Cancer.
    Sidorova EA; Zhernov YV; Antsupova MA; Khadzhieva KR; Izmailova AA; Kraskevich DA; Belova EV; Simanovsky AA; Shcherbakov DV; Zabroda NN; Mitrokhin OV
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet, microRNAs and prostate cancer.
    Saini S; Majid S; Dahiya R
    Pharm Res; 2010 Jun; 27(6):1014-26. PubMed ID: 20221895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs: novel regulators in the hallmarks of human cancer.
    Ruan K; Fang X; Ouyang G
    Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microRNAs in the development, prognosis and therapeutic response of patients with prostate cancer.
    Ghafouri-Fard S; Shoorei H; Taheri M
    Gene; 2020 Oct; 759():144995. PubMed ID: 32721477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.